Cargando…
Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
Metastases are hard to detect and treat, and they cause most cancer-related deaths. The relative lack of therapies targeting metastases represents a major unmet clinical need. The extracellular matrix (ECM) forms a major component of the tumor microenvironment in both primary and metastatic tumors,...
Autores principales: | Jailkhani, Noor, Clauser, Karl R., Mak, Howard H., Rickelt, Steffen, Tian, Chenxi, Whittaker, Charles A., Tanabe, Kenneth K., Purdy, Stephen R., Carr, Steven A., Hynes, Richard O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267678/ https://www.ncbi.nlm.nih.gov/pubmed/37098922 http://dx.doi.org/10.1158/0008-5472.CAN-22-1532 |
Ejemplares similares
-
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
por: Naba, Alexandra, et al.
Publicado: (2014) -
Intratumoral nanobody–IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in mice
por: Lutz, Emi A, et al.
Publicado: (2022) -
Comprehensive analysis of cutaneous and uveal melanoma liver metastases
por: Hoefsmit, Esmee P, et al.
Publicado: (2020) -
PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival
por: Atreya, Chloe E, et al.
Publicado: (2013) -
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
por: Kabraji, Sheheryar, et al.
Publicado: (2023)